Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
USS | Ann: USS NTA 18-03-2024 $6.96946 | 08:02 | 0 | 16 | |||
|
|||||||
USS | Ann: USS NTA 15-03-2024 $6.92660 | 18/03/24 | 0 | 23 | |||
|
|||||||
USS | Ann: USS NTA 14-03-2024 $6.99466 | 15/03/24 | 0 | 37 | |||
|
|||||||
USS | Ann: USS NTA 13-03-2024 $6.97931 | 14/03/24 | 0 | 34 | |||
|
|||||||
USS | Ann: USS NTA 12-03-2024 $6.93907 | 13/03/24 | 0 | 35 | |||
|
|||||||
USS | Ann: USS NTA 11-03-2024 $6.94409 | 12/03/24 | 0 | 30 | |||
|
|||||||
USS | Ann: USS NTA 08-03-2024 $6.98946 | 11/03/24 | 0 | 40 | |||
|
|||||||
USS | Ann: USS NTA 07-03-2024 $6.97506 | 08/03/24 | 0 | 40 | |||
|
See All Discussions